Allergic Conjunctivitis Market

Allergic conjunctivitis market accounted for 2.6 billion in 2020 and is estimated to be US$ 4.2 billion by 2029 and is anticipated to register a CAGR of 5.3%.

The report "Global Allergic Conjunctivitis Market, By Type (Bacterial, Allergic, Viral, and Chemical), By Drug Class (Antibiotics, Mast Cell Stabilizers, Steroids, and others), By End User (Hospitals and Clinics and Specialty Centers), and By Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Trends, Analysis and Forecast till 2029”.

Key Highlights:

• In April 2020, Alembic Pharmaceuticals Limited announced that the company had received an abbreviated new drug application (ANDA) approval from the FDA for their generic ophthalmic solution of alcaftadine for the disease indication of allergic conjunctivitis.
• In February 2020, Alcon announced the launch of Pataday Once Daily Relief, first ever and only eye drop to provide all day allergy itch relief arising from allergic conjunctivitis without a prescription.

Analyst View:

Rise in air pollution

The global allergic conjunctivitis treatment market is also driven by rise in air pollution in major cities across the globe. A research study published in 2016 by the National Center for Biotechnology Information (NCBI) revealed that ambient air pollution and weather changes are responsible for the occurrence as well as worsening of allergic conjunctivitis. This is attributed to the conjunctiva being sensitive to environmental particles along with direct contact of conjunctiva with the outside environment. Hence, rise in air pollution propels the global allergic conjunctivitis treatment market.

Increase in incidence and prevalence of allergic conjunctivitis

The global allergic conjunctivitis treatment market is driven by increase in incidence of allergic conjunctivitis. A research study published in 2017 by the National Institutes of Health (NIH) indicated that the number of patients being diagnosed with allergic conjunctivitis is increasing globally. This increase in incidence rate propels the global allergic conjunctivitis treatment market.

Key Market Insights from the report:        

The global allergic conjunctivitis market accounted for 2.6 billion in 2020 and is estimated to be US$ 4.2 billion by 2029 and is anticipated to register a CAGR of 5.3%. The market report has been segmented on the basis of type, drug class, end user and region.

• Depending upon type, the viral segment is projected to grow at highest CAGR over the forecast period because viral conjunctivitis is more prevalent in summer and is the most common cause of infectious conjunctivitis across the globe.
• Depending end user, the hospital & clinics segment is projected to grow at highest CAGR over the forecast period.
• By region, North America is the largest market for allergic conjunctivitis treatments due to high prevalence of allergic conjunctivitis. According to the American Society of Cataract and Refractive Surgery (ASCRS), around 50 million to 60 million people in the U.S. had allergic conjunctivitis in 2015.

Before purchasing this report, request a sample or make an inquiry by clicking the following link:

https://www.prophecymarketinsights.com/market_insight/Global-Allergic-Conjunctivitis-Market-4489

Competitive Landscape:

The prominent player operating in the global allergic conjunctivitis market includes Akorn Incorporated, Allergan, Bausch Health Companies, Inc., Novartis AG, Santen Pharmaceutical Co. Ltd., Sun Pharma Advanced Research Company Ltd., Ocular Therapeutix, Inc., Sirion Therapeutics, Inc., Boehringer Ingelheim International GmbH, Atopix Therapeutics Ltd., and Auven Therapeutics.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

• Explains an overview of the product portfolio, including product development, planning, and positioning
• Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
• Detailed analysis of the market revenue over the forecasted period.
• Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
• Study on the segments that are anticipated to dominate the market.
• Study on the regional analysis that is expected to register the highest growth over the forecast period

Key Topics Covered

1. Introduction

• Study Deliverables
• Study Assumptions
• Scope of the Study

2. Research Methodology
3. Executive Summary

• Opportunity Map Analysis
• Market at Glance
• Market Share (%) and BPS Analysis, by Region
• Competitive Landscape
• Heat Map Analysis 
• Market Presence and Specificity Analysis

4. Investment Analysis
5. Competitive Analysis

To know more

Contact Us:

Sales

Prophecy Market Insights

Email- sales@prophecymarketinsights.com

Article source: https://article-realm.com/article/Arts-Entertainment/Celebrities/30212-Allergic-Conjunctivitis-Market.html